Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
Gliomas are characterised by local infiltration, migration of tumour cells across long distances and sustained angiogenesis; therefore, proteins involved in these processes are most likely important. Such candidates are semaphorins involved in axon guidance and cell migration. In addition, semaphorins regulate tumour progression and angiogenesis. For cell signalling, class-4 semaphorins bind directly to plexins, whereas class-3 semaphorins require additional neuropilin (NRP) receptors that also bind VEGF(165). The anti-angiogenic activity of class-3 semaphorins can be explained by competition with VEGF(165) for NRP binding. In this study, we analysed the expressions of seven semaphorins of class-3, SEMA4D, VEGF and the NRP1 and NRP2 receptors in 38 adult glial tumours. In these tumours, SEMA3B, SEMA3G and NRP2 expressions were related to prolonged survival. In addition, SEMA3D expression was reduced in high-grade as compared with low-grade gliomas. In contrast, VEGF correlated with higher grade and poor survival. Thus, our data suggest a function for a subset of class-3 semaphorins as inhibitors of tumour progression, and the prognostic value of the VEGF/SEMA3 balance in adult gliomas. Moreover, in multivariate analysis, SEMA3G was found to be the only significant prognostic marker.
Karayan-Tapon
L
L
Université de Poitiers, EA 3805, CHU de Poitiers, 2 rue de la Milétrie, BP 577, Poitiers F-86021, France.
Wager
M
M
Guilhot
J
J
Levillain
P
P
Marquant
C
C
Clarhaut
J
J
Potiron
V
V
Roche
J
J
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000235:genetics*; D005260:Female; D005910:Glioma / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D039921:Neuropilins / Q000235:genetics*; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D039961:Semaphorins / Q000235:genetics*; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
D014408:Biomarkers, Tumor; D039921:Neuropilins; D012333:RNA, Messenger; D039961:Semaphorins; D042461:Vascular Endothelial Growth Factor A
Oncogene. 2007 Aug 16;26(38):5577-86
17369861
Front Biosci. 2005 Jan 01;10:751-60
15569615
Am J Pathol. 2000 Mar;156(3):939-50
10702410
Cancer Lett. 2002 Dec 15;188(1-2):1-7
12406541
Int J Cancer. 1999 Feb 19;84(1):10-8
9988225
Cell. 1999 Oct 1;99(1):71-80
10520995
Development. 1998 Dec;125(24):5043-53
9811588
Neuron. 2000 Jan;25(1):29-41
10707970
Anticancer Res. 2004 Mar-Apr;24(2B):547-52
15160992
Oncogene. 2004 Jul 1;23(30):5131-7
15184888
EMBO J. 1997 Oct 15;16(20):6077-86
9321387
Cancer Res. 2005 May 15;65(10):4051-8
15899794
Glia. 2003 Jun;42(4):379-89
12730958
Cancer Cell. 2007 Jan;11(1):53-67
17222790
Hippocampus. 2003;13(1):1-20
12625453
Cell. 1997 Aug 22;90(4):739-51
9288753
FASEB J. 2000 Dec;14(15):2532-9
11099472
Cell. 1997 Aug 22;90(4):753-62
9288754
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9017-22
16754882
J Exp Med. 2008 May 12;205(5):1155-71
18458115
J Cell Biol. 1999 Jul 12;146(1):233-42
10402473
Nat Cell Biol. 2002 Sep;4(9):720-4
12198496
APMIS. 2004 Apr-May;112(4-5):257-63
15233640
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13954-9
11717452
Int J Cancer. 2000 Nov 15;88(4):584-92
11058875
Crit Rev Immunol. 2003;23(1-2):65-81
12906260
N Engl J Med. 2005 Mar 10;352(10):997-1003
15758010
Dev Neurobiol. 2007 Aug;67(9):1216-31
17514715
Cancer Res. 2002 Jan 15;62(2):542-6
11809707
J Biol Chem. 2000 Jun 16;275(24):18040-5
10748121
J Neurosci. 2005 Apr 6;25(14):3613-20
15814792
Exp Neurol. 2003 Jul;182(1):142-50
12821384
Cell. 1999 May 28;97(5):551-2
10367884
J Neurooncol. 2001 Jun;53(2):161-76
11716068
J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9
11895036
Cancer. 2007 Jul 1;110(1):164-72
17520683
Genome Biol. 2006;7(3):211
16584533
Brain Res. 1999 Mar 27;823(1-2):67-79
10095013
J Clin Invest. 2004 Nov;114(9):1260-71
15520858
Neuroscience. 2005;131(4):853-69
15749340
Cancer Res. 2007 Feb 15;67(4):1451-60
17308083
Am J Pathol. 1998 Jul;153(1):255-62
9665486
J Biol Chem. 2007 Mar 2;282(9):6899-905
17204469
Cancer Metastasis Rev. 2007 Dec;26(3-4):421-31
17768598
Cancer Res. 1995 Mar 1;55(5):1189-93
7532545
Cancer Res. 2002 May 1;62(9):2637-43
11980661
Cancer Res. 2007 Nov 1;67(21):10309-16
17974973
Neoplasia. 2005 May;7(5):457-65
15967098
Nat Rev Neurosci. 2007 Aug;8(8):610-22
17643088
Cancer Res. 2004 Feb 1;64(3):1008-15
14871832
Lancet. 2002 Mar 23;359(9311):1011-8
11937180
Neoplasia. 2002 Jan-Feb;4(1):82-7
11922394
Nat Clin Pract Oncol. 2007 Jun;4(6):362-74
17534392
J Cell Biochem. 2002;85(2):357-68
11948691
Cancer Res. 2004 Aug 1;64(15):5212-24
15289326
J Clin Oncol. 2007 Sep 10;25(26):4127-36
17827463
Nature. 1992 Oct 29;359(6398):845-8
1279432
Cancer Biol Ther. 2005 Jun;4(6):659-68
15917651
Cancer Res. 2007 Sep 15;67(18):8708-15
17875711
Genes Cells. 2005 Aug;10(8):785-92
16098142
Neuron. 2000 Jan;25(1):43-56
10707971
J Neurooncol. 1997 Dec;35(3):211-22
9440021
Cancer. 2002 Nov 15;95(10):2196-201
12412174
Br J Cancer. 2006 Oct 23;95(8):1062-9
17047653
Neuron. 1995 May;14(5):949-59
7748562
Blood. 2006 Sep 1;108(5):1661-7
16684957
Cell. 1998 Mar 20;92(6):735-45
9529250
Blood. 2005 Jun 1;105(11):4321-9
15632204